0001209191-18-031155.txt : 20180517 0001209191-18-031155.hdr.sgml : 20180517 20180517183443 ACCESSION NUMBER: 0001209191-18-031155 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180515 FILED AS OF DATE: 20180517 DATE AS OF CHANGE: 20180517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McLaughlin Erica CENTRAL INDEX KEY: 0001740348 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-05667 FILM NUMBER: 18844553 MAIL ADDRESS: STREET 1: C/O CABOT CORPORATION STREET 2: TWO SEAPORT LANE, SUITE 1300 CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CABOT CORP CENTRAL INDEX KEY: 0000016040 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 042271897 STATE OF INCORPORATION: DE FISCAL YEAR END: 0939 BUSINESS ADDRESS: STREET 1: TWO SEAPORT LANE SUITE 1300 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173450100 MAIL ADDRESS: STREET 1: TWO SEAPORT LANE SUITE 1300 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: CABOT GODFREY L INC DATE OF NAME CHANGE: 19680418 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2018-05-15 0 0000016040 CABOT CORP CBT 0001740348 McLaughlin Erica C/O CABOT CORPORATION TWO SEAPORT LANE, SUITE 1300 BOSTON MA 02210 0 1 0 0 Senior Vice President, CFO Common Stock 9419 D Common Stock 1.37 I Through the Trustee for the Corporation's 401(k) Plan Employee Stock Option (Right to Buy) 46.03 2024-11-13 Common Stock 2295 D Employee Stock Option (Right to Buy) 39.54 2025-11-11 Common Stock 3293 D Employee Stock Option (Right to Buy) 50.46 2026-11-10 Common Stock 3534 D Employee Stock Option (Right to Buy) 62.24 2027-11-09 Common Stock 3151 D Phantom Stock 61.65 Common Stock 810.233 D Includes 1,908 performance based units earned on the basis of the Corporation's performance in fiscal year 2016 and 2017 (which remain subject to time-based vesting) and 4,842 units subject to time-based vesting. Reflects retirement plan contributions by the Corporation. The option vested over a three year period as follows: 30% on November 14, 2015, 30% on November 14, 2016 and 40% on November 14, 2017. The option vests over a three year period as follows: 30% on November 12, 2016, 30% on November 12, 2017 and 40% on November 12, 2018. The option vests over a three year period as follows: 30% on November 11, 2017, 30% on November 11, 2018 and 40% on November 11, 2019. The option vests over a three year period as follows: 30% on November 10, 2018, 30% on November 10, 2019 and 40% on November 10, 2020 Each share of phantom stock is the economic equivalent of one share of Cabot Corporation common stock. The shares of phantom stock will be settled in shares of Cabot Corporation common stock upon termination of her employment with Cabot Corporation. By: Kristine L. Ouimet, pursuant to a power of attorney from Erica McLaughlin 2018-05-17 EX-24 2 attachment1.htm EX-24 DOCUMENT

Exhibit 24

POWER OF ATTORNEY

	Know all by these presents, that the undersigned hereby constitutes and
appoints each of Jane A. Bell, Brian A. Berube, Karen Kalita and Kristine
Ouimet, signing singly, the undersigned's true and lawful attorney-in-fact to:

(1)	  execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of Cabot Corporation (the "Company"),
Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange
Act of 1934 and the rules thereunder;

(2)	  do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or 5
(including executing and filing a Form I.D.), complete and execute any amendment
or amendments thereto, and timely file such form with the United States
Securities and Exchange Commission and any stock exchange or similar authority;
and

(3)	  take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

	The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.

	This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.  The undersigned hereby revokes any previous powers
of attorney delivered to the Company concerning the subject matter hereof.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 7th day of May, 2018.


/s/ Erica McLaughlin
Signature